Contact
Please use this form to send email to PR contact of this press release:
Santen and TRACON Announce Initiation of a Phase 2a Study of DE-122 for the Treatment of Wet Age-Related Macular Degeneration
TO:
Please use this form to send email to PR contact of this press release:
Santen and TRACON Announce Initiation of a Phase 2a Study of DE-122 for the Treatment of Wet Age-Related Macular Degeneration
TO: